Yestar Healthcare Holdings Company Limited provided consolidated earnings guidance for the six months ended 30 June 2022. The company is expected to record an unaudited consolidated net loss of the Group of approximately RMB 180.2 million and an unaudited consolidated net loss attributable to the owners of the parent of approximately RMB 161.5 million for the six months ended 30 June 2022 as compared to an unaudited consolidated net profit of the Group of approximately RMB 120.9 million and an unaudited consolidated net profit attributable to the owners of the parent of approximately RMB 111.9 million for the six months ended 30 June 2021.
Yestar Healthcare Holdings Company Limited
Equities
2393
KYG9843W1125
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.048 HKD | 0.00% | -4.00% | +6.67% |
05-07 | Yestar Healthcare Holdings Company Limited Announces Change of Principal Place of Business | CI |
04-26 | Yestar Healthcare Narrows Loss in 2023 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.67% | 14.33M | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+3.49% | 40.74B | |
+19.92% | 31.6B | |
+16.38% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- 2393 Stock
- News Yestar Healthcare Holdings Company Limited
- Yestar Healthcare Holdings Company Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022